サマリー

オリゴヌクレオチド合成の世界市場 2023-2027
オリゴヌクレオチド合成市場は2022-2027年に2,870.69百万米ドルの成長が予測され、予測期間中のCAGRは13.47%で加速すると予測されています。この調査レポートは、オリゴヌクレオチド合成市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、製薬およびバイオテクノロジー分野での研究活動の増加、治療および診断ツールとしてのオリゴヌクレオチドの使用の増加、オリゴヌクレオチド合成における技術革新の出現によって牽引されています。
Technavioのオリゴヌクレオチド合成市場は以下のようにセグメント化されている：
用途別
- PCRプライマー
- 蛍光in situハイブリダイゼーション
- PCRアッセイとパネル
- DNAマイクロアレイ
- その他
エンドユーザー別
- 製薬・バイオテクノロジー企業
- 研究・学術機関
- 診断研究所
- 病院
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間のオリゴヌクレオチド合成市場の成長を促進する主な理由の1つとして、新しいオリゴヌクレオチド治療薬の研究開発への注目の高まりを挙げている。また、研究費の増加や低コストでハイスループットなオリゴヌクレオチド合成に対する需要の高まりは、市場の大きな需要につながる。
オリゴヌクレオチド合成市場に関するレポートは以下の分野をカバーしている：
- オリゴヌクレオチド合成市場のサイジング
- オリゴヌクレオチド合成市場予測
- オリゴヌクレオチド合成市場の産業分析
本レポートでは、オリゴヌクレオチド合成市場の主要ベンダーであるAgilent Technologies Inc.、味の素株式会社、Alnylam Pharmaceuticals Inc.、Bio Synthesis Inc、Biotage AB、Danaher Corp.、Eurofins Scientific SE、General Electric Co.、Ionis Pharmaceuticals Inc.、Kaneka Corp.、LGC Science Group Holdings Ltd.、Maravai LifeSciences Holdings Inc.、Merck KGaA、Mettler Toledo International Inc.、QIAGEN NV、Sarepta Therapeutics Inc.、Synbio Technologies、Thermo Fisher Scientific Inc.、Biogen Inc.など。また、オリゴヌクレオチド合成市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものである。
この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/oligonucleotide-synthesis-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global oligonucleotide synthesis market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global oligonucleotide synthesis market 2017 - 2021 ($ billion)
o 4.2 Applications Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Applications Segment 2017 - 2021 ($ billion)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 PCR primers - Market size and forecast 2022-2027
o Exhibit 34: Chart on PCR primers - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on PCR primers - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on PCR primers - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on PCR primers - Year-over-year growth 2022-2027 (%)
o 6.4 Fluorescence in situ hybridization - Market size and forecast 2022-2027
o Exhibit 38: Chart on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
o 6.5 PCR assays and panels - Market size and forecast 2022-2027
o Exhibit 42: Chart on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on PCR assays and panels - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on PCR assays and panels - Year-over-year growth 2022-2027 (%)
o 6.6 DNA microarrays - Market size and forecast 2022-2027
o Exhibit 46: Chart on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on DNA microarrays - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on DNA microarrays - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ billion)
o Exhibit 55: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 56: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 57: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 58: Chart on Comparison by End-user
o Exhibit 59: Data Table on Comparison by End-user
o 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
o Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
o 7.4 Research and academic institutes - Market size and forecast 2022-2027
o Exhibit 64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
o 7.5 Diagnostic laboratories - Market size and forecast 2022-2027
o Exhibit 68: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
o 7.6 Hospitals - Market size and forecast 2022-2027
o Exhibit 72: Chart on Hospitals - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Data Table on Hospitals - Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by End-user
o Exhibit 76: Market opportunity by End-user ($ billion)
o Exhibit 77: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 81: Chart on Geographic comparison
o Exhibit 82: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 111: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 121: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 123: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 124: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 125: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 126: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 127: Agilent Technologies Inc. - Overview
o Exhibit 128: Agilent Technologies Inc. - Business segments
o Exhibit 129: Agilent Technologies Inc. - Key offerings
o Exhibit 130: Agilent Technologies Inc. - Segment focus
o 12.4 Alnylam Pharmaceuticals Inc.
o Exhibit 131: Alnylam Pharmaceuticals Inc. - Overview
o Exhibit 132: Alnylam Pharmaceuticals Inc. - Product / Service
o Exhibit 133: Alnylam Pharmaceuticals Inc. - Key news
o Exhibit 134: Alnylam Pharmaceuticals Inc. - Key offerings
o 12.5 Biogen Inc.
o Exhibit 135: Biogen Inc. - Overview
o Exhibit 136: Biogen Inc. - Product / Service
o Exhibit 137: Biogen Inc. - Key offerings
o 12.6 Biotage AB
o Exhibit 138: Biotage AB - Overview
o Exhibit 139: Biotage AB - Product / Service
o Exhibit 140: Biotage AB - Key news
o Exhibit 141: Biotage AB - Key offerings
o 12.7 Danaher Corp.
o Exhibit 142: Danaher Corp. - Overview
o Exhibit 143: Danaher Corp. - Business segments
o Exhibit 144: Danaher Corp. - Key news
o Exhibit 145: Danaher Corp. - Key offerings
o Exhibit 146: Danaher Corp. - Segment focus
o 12.8 Eurofins Scientific SE
o Exhibit 147: Eurofins Scientific SE - Overview
o Exhibit 148: Eurofins Scientific SE - Business segments
o Exhibit 149: Eurofins Scientific SE - Key news
o Exhibit 150: Eurofins Scientific SE - Key offerings
o Exhibit 151: Eurofins Scientific SE - Segment focus
o 12.9 Ionis Pharmaceuticals Inc.
o Exhibit 152: Ionis Pharmaceuticals Inc. - Overview
o Exhibit 153: Ionis Pharmaceuticals Inc. - Business segments
o Exhibit 154: Ionis Pharmaceuticals Inc. - Key news
o Exhibit 155: Ionis Pharmaceuticals Inc. - Key offerings
o Exhibit 156: Ionis Pharmaceuticals Inc. - Segment focus
o 12.10 Kaneka Corp.
o Exhibit 157: Kaneka Corp. - Overview
o Exhibit 158: Kaneka Corp. - Business segments
o Exhibit 159: Kaneka Corp. - Key offerings
o Exhibit 160: Kaneka Corp. - Segment focus
o 12.11 LGC Science Group Holdings Ltd.
o Exhibit 161: LGC Science Group Holdings Ltd. - Overview
o Exhibit 162: LGC Science Group Holdings Ltd. - Product / Service
o Exhibit 163: LGC Science Group Holdings Ltd. - Key offerings
o 12.12 Maravai LifeSciences Holdings Inc.
o Exhibit 164: Maravai LifeSciences Holdings Inc. - Overview
o Exhibit 165: Maravai LifeSciences Holdings Inc. - Business segments
o Exhibit 166: Maravai LifeSciences Holdings Inc. - Key offerings
o Exhibit 167: Maravai LifeSciences Holdings Inc. - Segment focus
o 12.13 Merck KGaA
o Exhibit 168: Merck KGaA - Overview
o Exhibit 169: Merck KGaA - Business segments
o Exhibit 170: Merck KGaA - Key news
o Exhibit 171: Merck KGaA - Key offerings
o Exhibit 172: Merck KGaA - Segment focus
o 12.14 Mettler Toledo International Inc.
o Exhibit 173: Mettler Toledo International Inc. - Overview
o Exhibit 174: Mettler Toledo International Inc. - Business segments
o Exhibit 175: Mettler Toledo International Inc. - Key offerings
o Exhibit 176: Mettler Toledo International Inc. - Segment focus
o 12.15 Sarepta Therapeutics Inc
o Exhibit 177: Sarepta Therapeutics Inc - Overview
o Exhibit 178: Sarepta Therapeutics Inc - Product / Service
o Exhibit 179: Sarepta Therapeutics Inc - Key offerings
o 12.16 Synbio Technologies
o Exhibit 180: Synbio Technologies - Overview
o Exhibit 181: Synbio Technologies - Product / Service
o Exhibit 182: Synbio Technologies - Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 183: Thermo Fisher Scientific Inc. - Overview
o Exhibit 184: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 185: Thermo Fisher Scientific Inc. - Key news
o Exhibit 186: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 187: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 188: Inclusions checklist
o Exhibit 189: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 190: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 191: Research methodology
o Exhibit 192: Validation techniques employed for market sizing
o Exhibit 193: Information sources
o 13.5 List of abbreviations
o Exhibit 194: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global oligonucleotide synthesis market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Applications Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on PCR primers - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on PCR primers - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on PCR primers - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on PCR primers - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on PCR assays and panels - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on PCR assays and panels - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on DNA microarrays - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on DNA microarrays - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ billion)
Exhibits55: Data Table on Market opportunity by Application ($ billion)
Exhibits56: Chart on End-user - Market share 2022-2027 (%)
Exhibits57: Data Table on End-user - Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by End-user
Exhibits59: Data Table on Comparison by End-user
Exhibits60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Hospitals - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Hospitals - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits76: Market opportunity by End-user ($ billion)
Exhibits77: Data Table on Market opportunity by End-user ($ billion)
Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits81: Chart on Geographic comparison
Exhibits82: Data Table on Geographic comparison
Exhibits83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ billion)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits121: Impact of drivers and challenges in 2022 and 2027
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: Agilent Technologies Inc. - Overview
Exhibits128: Agilent Technologies Inc. - Business segments
Exhibits129: Agilent Technologies Inc. - Key offerings
Exhibits130: Agilent Technologies Inc. - Segment focus
Exhibits131: Alnylam Pharmaceuticals Inc. - Overview
Exhibits132: Alnylam Pharmaceuticals Inc. - Product / Service
Exhibits133: Alnylam Pharmaceuticals Inc. - Key news
Exhibits134: Alnylam Pharmaceuticals Inc. - Key offerings
Exhibits135: Biogen Inc. - Overview
Exhibits136: Biogen Inc. - Product / Service
Exhibits137: Biogen Inc. - Key offerings
Exhibits138: Biotage AB - Overview
Exhibits139: Biotage AB - Product / Service
Exhibits140: Biotage AB - Key news
Exhibits141: Biotage AB - Key offerings
Exhibits142: Danaher Corp. - Overview
Exhibits143: Danaher Corp. - Business segments
Exhibits144: Danaher Corp. - Key news
Exhibits145: Danaher Corp. - Key offerings
Exhibits146: Danaher Corp. - Segment focus
Exhibits147: Eurofins Scientific SE - Overview
Exhibits148: Eurofins Scientific SE - Business segments
Exhibits149: Eurofins Scientific SE - Key news
Exhibits150: Eurofins Scientific SE - Key offerings
Exhibits151: Eurofins Scientific SE - Segment focus
Exhibits152: Ionis Pharmaceuticals Inc. - Overview
Exhibits153: Ionis Pharmaceuticals Inc. - Business segments
Exhibits154: Ionis Pharmaceuticals Inc. - Key news
Exhibits155: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits156: Ionis Pharmaceuticals Inc. - Segment focus
Exhibits157: Kaneka Corp. - Overview
Exhibits158: Kaneka Corp. - Business segments
Exhibits159: Kaneka Corp. - Key offerings
Exhibits160: Kaneka Corp. - Segment focus
Exhibits161: LGC Science Group Holdings Ltd. - Overview
Exhibits162: LGC Science Group Holdings Ltd. - Product / Service
Exhibits163: LGC Science Group Holdings Ltd. - Key offerings
Exhibits164: Maravai LifeSciences Holdings Inc. - Overview
Exhibits165: Maravai LifeSciences Holdings Inc. - Business segments
Exhibits166: Maravai LifeSciences Holdings Inc. - Key offerings
Exhibits167: Maravai LifeSciences Holdings Inc. - Segment focus
Exhibits168: Merck KGaA - Overview
Exhibits169: Merck KGaA - Business segments
Exhibits170: Merck KGaA - Key news
Exhibits171: Merck KGaA - Key offerings
Exhibits172: Merck KGaA - Segment focus
Exhibits173: Mettler Toledo International Inc. - Overview
Exhibits174: Mettler Toledo International Inc. - Business segments
Exhibits175: Mettler Toledo International Inc. - Key offerings
Exhibits176: Mettler Toledo International Inc. - Segment focus
Exhibits177: Sarepta Therapeutics Inc - Overview
Exhibits178: Sarepta Therapeutics Inc - Product / Service
Exhibits179: Sarepta Therapeutics Inc - Key offerings
Exhibits180: Synbio Technologies - Overview
Exhibits181: Synbio Technologies - Product / Service
Exhibits182: Synbio Technologies - Key offerings
Exhibits183: Thermo Fisher Scientific Inc. - Overview
Exhibits184: Thermo Fisher Scientific Inc. - Business segments
Exhibits185: Thermo Fisher Scientific Inc. - Key news
Exhibits186: Thermo Fisher Scientific Inc. - Key offerings
Exhibits187: Thermo Fisher Scientific Inc. - Segment focus
Exhibits188: Inclusions checklist
Exhibits189: Exclusions checklist
Exhibits190: Currency conversion rates for US$
Exhibits191: Research methodology
Exhibits192: Validation techniques employed for market sizing
Exhibits193: Information sources
Exhibits194: List of abbreviations